HiFiBiO
hifibio.comLocations
Paris, France · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2013
Hi Fi Bi O Therapeutics is pioneering curative immunotherapies for patients with high unmet medical needs through its unique Drug Intelligence Science (DIS®) platform. This platform leverages proprietary single cell technology and AI/ML analytics to enhance clinical success in target discovery, antibody selection, and predictive biomarker identification. Since its inception in 2017, the company has completed 4 Phase I dose escalation trials, filed and cleared 6 INDs, discovered 8 clinical candidates, and established over 12 partnerships, positioning itself as a leader in therapeutic innovation.
Something looks off?Open jobs at HiFiBiO
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.